• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Eitan Medical Receives FDA Clearance for Sapphire Infusion System

    Researchers Successfully ‘Fine Tune’ New Thermoplastic Biomaterial

    RSIP Vision Announces Versatile Medical Image Segmentation Tool

    Vance Street Capital Adds Operating Partner

    Haemonetics to Acquire Cardiva for Up to $510M
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Fixing Face Mask Form and Function

    The Heart of the Matter: Trends in Cardiology

    Virtually the Same? The Challenges of Online Conferences

    Digital Health Delivers During a Year for the Ages

    Advanced Technology for Staking and Swaging Medical Plastics
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    maxon

    Element

    Medicoil

    Medbio LLC

    Creganna Medical, part of TE Connectivity
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Meeting Critical Ventilator Product Requirements Amid Pandemic

    Impact of COVID-19 on the Medtech Supply Chain

    Finding the Upside to a Challenging Year

    Preparing Your Design Controls for FDA Approval

    A 'Trial and Error' Approach to Micromolded Parts
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Creganna Medical, part of TE Connectivity

    Element

    MW Life Sciences

    Medbio LLC

    Qosina Corp.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Owlstone Medical Appoints Five Experts to Scientific Advisory Board

    Additions form a key strategic resource to advise on Breath Biopsy platform, product, and study development.

    Owlstone Medical Appoints Five Experts to Scientific Advisory Board
    Related CONTENT
    • Gas Sensing Gut Pill Beats Breath Test Diagnosis
    • Low-Cost Plastic Sensors Could Monitor a Range of Health Conditions
    • Micro Medical Solutions Completes Formation of International Scientific Advisory Board
    • Vibrent Health Joins RADAR-CNS Program to Develop Scalable Analytics Platform for Health Wearables
    • Medtronic Study Confirms Feasibility of New Extravascular Approach to ICD Therapy
    Owlstone Medical08.28.18
    Owlstone Medical, a diagnostics company developing a breathalyzer for disease, has expanded its Scientific Advisory Board (SAB) with the appointment of five experts in a range of high-value disciplines.
     
    Owlstone Medical has been advised by Prof. Sir Bruce Ponder, Emeritus Professor of Oncology at the University of Cambridge, since June 2017. In this time, Ponder has played an important role supporting the application of Owlstone Medical’s Breath Biopsy platform to solve some of the most challenging questions in oncology, in particular screening for the early detection of cancer when treatment can be most effective. was the inaugural director of the Cancer Research UK Cambridge Institute (CRUKCI). He became a Fellow of the Royal Society (FRS) in 2001, was knighted for Services to Medicine in 2008, and was awarded the Cancer Research UK Lifetime Achievement Prize in 2013. Ponder has made enormous contributions to the field of oncology, including setting up one of the first specialist clinics for families with cancer, involvement in the discovery of several genes predisposing to cancer, and advances in our understanding of how cancer develops. His group at the CRUKCI is investigating how variations in multiple genes combine to contribute to susceptibility to breast and lung cancer, with the aim to identify high risk groups for targeted cancer screening and prevention.

    Ponder is now being joined by experts in areas critical to the development of the business: oncology, personalized medicine, breath testing, biomarker discovery, mass spectrometry, and toxicology and pharmacology. Owlstone Medical’s SAB will provide support and guide the company on product development, technology platform evolution, and clinical program design during its next phase of growth.
     
    Dr. Patrick Bossuyt
    Bossuyt is professor of clinical epidemiology at the University of Amsterdam and is chair of the Division of Public Health & Clinical Methods in the Academic Medical Center. He leads the Biomarker and Test Evaluation Research program (BiTE) in Amsterdam, which aims to appraise and develop methods for evaluating medical tests and biomarkers, and to apply these methods in relevant clinical studies. His scientific work spans a broad range of topics in clinical research, developed in close collaboration with clinical departments in the in the Academic Medical Center, with an emphasis on studies of the effectiveness of clinical interventions to guide clinical recommendations and coverage decisions.

    The BiTE Program aims to appraise and develop methods for evaluating medical tests and biomarkers, and to apply these methods in relevant clinical studies. In doing so, the program wants to strengthen the evidence-base for rational decision-making about the use of tests and test strategies in healthcare. Bossuyt spearheaded the STARD initiative for the improved reporting of diagnostic test accuracy studies. Bossuyt has authored and co-authored several hundred publications in peer-reviewed journals and serves on the editorial board of a number of these, including Radiology and Clinical Chemistry. He is a member of several national and international advisory committees. He chairs the Scientific Advisory Committee of the Dutch Health Insurance Board, overseeing the national healthcare benefits package.
     
    Dr. Christian Frezza
    Frezza is an MRC Programme Leader at the MRC Cancer Unit, University of Cambridge. His research is focused on understanding the role of altered metabolism in cancer, particularly investigating how small molecule metabolites affect the process of tumorigenesis with the goal of to exploit this knowledge to pioneer novel tools for cancer diagnosis and therapy. He studied Medicinal Chemistry at the University of Padova, Italy, and gained his MSc in 2002, after a period of research on mitochondrial toxicity induced by photoactivable anticancer drugs.
     
    Frezza then joined the laboratory of Luca Scorrano in Padova to start a doctorate on mitochondrial dynamics and apoptosis. In 2008, he moved to the Beatson Institute of Cancer Research in Glasgow as recipient of an EMBO Long Term Fellowship, where he investigated the role of mitochondrial defects in tumorigenesis. He moved to the MRC Cancer Unit in 2012, to take up his current position. His research is focused on understanding the role of altered metabolism in cancer, particularly investigating how small molecule metabolites affect the process of tumorigenesis. The major goal of his team is to exploit this knowledge to pioneer novel tools for cancer diagnosis and therapy.
     
    Dr. Chris A. Mayhew
    Mayhew is the director of the Institute for Breath Research at the University of Innsbruck and leads the Molecular Physics Group at the school of Physics and Astronomy at the University of Birmingham. His research involves the use of soft chemical ionization mass spectrometric techniques in the fields of health science, atmospheric chemistry and homeland security.

    Mayhew studied at the Imperial College of Science and Technology, where he graduated with distinction in 1981 in theoretical physics, and acquired his Ph.D. in molecular physics four years later. He continued his scientific work in the Chemistry Division of the Argonne National Laboratory in Chicago, Ill., where his interest in mass spectrometry was aroused. In 1987 Mayhew became Alexander von Humboldt fellow to the Physical Institute of the University of Bonn, where he was able to perform X-ray molecular mass spectrometric studies thanks to a special synchrotron light resource available in Bonn. During his stay in Germany, Mayhew took a permanent position at the school of Physics and Astronomy at the University of Birmingham (United Kingdom), where he has led the Molecular Physics Group for the next 29 years.
     
    Simultaneously, he created an internationally unique infrastructure in terms of instrumentation to carry out applied and basic research on ion molecule processes. Mayhew's multidisciplinary research involves the use of soft chemical ionization mass spectrometric techniques in the fields of health science, atmospheric chemistry and homeland security. On Oct. 1, 2016, he was appointed director of the Institute for Breath Research at the Leopold-Franzens-Universität Innsbruck, Austria, and on May 1, 2018, he was appointed professor of molecular physics at the University of Birmingham. He currently divides his time between Innsbruck and Birmingham.
     
    Dr. Anil Modak
    Formerly, associate director of Medical Products Research & Development at Cambridge Isotope Laboratories, Modak is an expert in stable isotope breath tests and consultant to leading life sciences and technology companies. He has been involved in the design, research, and development of noninvasive breath tests for personalized medicine using stable isotope substrates for the monitoring of disease severity/toxicity and the evaluation of drug metabolizing enzyme activity.
     
    He is the author of several recent patents and publications and numerous presentations at medical conferences around the world. He has reviewed several papers for reputed journals and authored two book chapters. He serves on the editorial board of the Journal of Breath Research, Journal of Pharmacogenomics & Pharmacoproteomics, and International Journal of Clinical Pharmacology & Toxicology. Modak's previous experience includes working for Ribozyme Pharmaceuticals in Boulder, Colo., and Monsanto in St Louis, Mo. His postdoctoral research was conducted at the University of Iowa and Kings College in London.
     
    Dr. Alan Boobis
    Boobis is professor of toxicology at Imperial College London. He retired from his position at the College as professor of biochemical pharmacology and director of the Public Health England/ Department of Health-supported Toxicology Unit in June 2017, after over 40 years. His main research interests lie in mechanistic toxicology, drug metabolism, mode of action and chemical risk assessment.

    Boobis' main research interests lie in mechanistic toxicology, drug metabolism, mode of action and chemical risk assessment. He has published around 250 original research papers (H-factor 80). He has been a member of several national and international advisory committees; he is currently a member of the U.K. Committee on Toxicity (chair), the WHO Study Group on Tobacco Product Regulation (TobReg), FAO/WHO JECFA (veterinary residues – previous chair) and FAO/WHO JMPR (pesticide residues - previous chair), amongst others. Boobis is a member and a past chairman of the Board of Trustees of ILSI (International Life Sciences Institute) HESI, past president of ILSI Europe and past chair of ILSI. He is involved in several HESI and ILSI Europe projects. Boobis is a fellow of several learned societies and has received a number of awards recognizing his contributions to toxicological sciences, including the civilian award of Officer of the British Empire (OBE).

    Billy Boyle, co-founder and CEO at Owlstone Medical, commented, “Owlstone Medical is in a period of rapid growth, with an increasing number of pharmaceutical companies partnering with us to identify novel breath biomarkers; several high profile clinical trials underway in the areas of lung, colorectal, and other forms of cancer; and multiple products in development targeted to reach market in the next twelve months. Supported by recent financing activities, we are set to accelerate our development, and so have established an advisory network to help guide us through our next phase of growth. The SAB forms a key strategic resource for the company and I am very pleased that we have been able to recruit such experienced and well-respected members to join us on our journey.”
     
    Owlstone Medical has developed a unique breathalyzer for disease. Its Breath Biopsy platform is creating a new industry category, based on the routine detection and analysis of volatile organic compound (VOC) biomarkers in breath, which has the potential to revolutionize healthcare. The ReCIVA Breath Sampler is the first standardized breath collection device designed to capture the VOC biomarkers present in breath, which are then analyzed using Owlstone Medical’s Breath Biopsy services and products.
     
    Owlstone Medical is developing breath tests for the early detection of lung and colorectal cancer. These are two of the most common cancer killers worldwide and represent multibillion dollar market opportunities. The company has an active clinical diagnostics/screening pipeline including the world’s largest breath-based clinical trials. The Breath Biopsy platform is also being deployed in the PAN cancer trial, a collaboration with Cancer Research UK studying the early detection of eight different cancer types in breath.
     
    Owlstone Medical was spun out of Owlstone Inc. in 2016 to develop and commercialize medical applications of its proprietary microchip chemical sensing technology, Field Asymmetric Ion Mobility Spectrometry (FAIMS), which is sold in the military and industrial sectors globally. The company has raised a total of $38.5 million in equity financing, and is backed by technology investor Horizons Ventures, and Aviva, a leading healthcare insurer. The company is headquartered in Cambridge, United Kingdom.
    Related Searches
    • institute
    • led
    • oct
    • iowa
    Suggested For You
    Gas Sensing Gut Pill Beats Breath Test Diagnosis Gas Sensing Gut Pill Beats Breath Test Diagnosis
    Low-Cost Plastic Sensors Could Monitor a Range of Health Conditions Low-Cost Plastic Sensors Could Monitor a Range of Health Conditions
    Micro Medical Solutions Completes Formation of International Scientific Advisory Board Micro Medical Solutions Completes Formation of International Scientific Advisory Board
    Vibrent Health Joins RADAR-CNS Program to Develop Scalable Analytics Platform for Health Wearables Vibrent Health Joins RADAR-CNS Program to Develop Scalable Analytics Platform for Health Wearables
    Medtronic Study Confirms Feasibility of New Extravascular Approach to ICD Therapy Medtronic Study Confirms Feasibility of New Extravascular Approach to ICD Therapy
    First Proton Imaging System to Be Installed in New NHS Therapy Center First Proton Imaging System to Be Installed in New NHS Therapy Center
    Technology Used to Map Mars Measures Treatment Technology Used to Map Mars Measures Treatment's Effect on Tumors
    Business and Medical Leaders Join BioSig Technologies Advisory Board Business and Medical Leaders Join BioSig Technologies Advisory Board
    Livongo Health Purchases Weight-Loss Startup Retrofit Livongo Health Purchases Weight-Loss Startup Retrofit
    AblaCor Allowed Five Ablation Catheter-Anchoring Patents AblaCor Allowed Five Ablation Catheter-Anchoring Patents
    Brexit: D-Day or the Y2K for Global Supply Chains? Brexit: D-Day or the Y2K for Global Supply Chains?
    Planning for Brexit Planning for Brexit
    Owlstone Medical Launches Breath Biopsy Kits  Owlstone Medical Launches Breath Biopsy Kits 
    ARMS Medical, Tissue Regenix BioSurgery Sign Distributor Agreement for DermaPure Allograft ARMS Medical, Tissue Regenix BioSurgery Sign Distributor Agreement for DermaPure Allograft
     Somahlution Enrolls First Patient in United Kingdom for European DuraGraft Registry Somahlution Enrolls First Patient in United Kingdom for European DuraGraft Registry

    Related Breaking News

    • Evonik Closes LACTEL Absorbable Polymers Acquisition

      Evonik Closes LACTEL Absorbable Polymers Acquisition

      LACTEL's biodegradable, PLGA-based polymers will be integrated into Evonik’s Health Care business.
      Evonik 01.21.21

    • Eitan Medical Receives FDA Clearance for Sapphire Infusion System

      Eitan Medical Receives FDA Clearance for Sapphire Infusion System

      Upgraded infusion system provides advanced performance and customization capabilities within hospital, pre-hospital and ambulatory environments.
      Eitan Medical 01.20.21

    • Materials
      Researchers Successfully ‘Fine Tune’ New Thermoplastic Biomaterial

      Researchers Successfully ‘Fine Tune’ New Thermoplastic Biomaterial

      Enables both the rate at which it degrades in the body and its mechanical properties to be controlled independently.
      University of Birmingham 01.20.21


    • Diagnostics
      RSIP Vision Announces Versatile Medical Image Segmentation Tool

      RSIP Vision Announces Versatile Medical Image Segmentation Tool

      Delivers efficient anatomical measurements and better treatment options.
      RSIP Visions 01.20.21

    • Vance Street Capital Adds Operating Partner

      Vance Street Capital Adds Operating Partner

      J. Mark King will work closely with leadership teams of portfolio companies in the medical vertical.
      Vance Street Capital LLC 01.20.21

    • Cardiovascular | Surgical
      Haemonetics to Acquire Cardiva for Up to $510M

      Haemonetics to Acquire Cardiva for Up to $510M

      Enhances penetration into the large and growing interventional cardiology and electrophysiology markets.
      PR Newswire 01.20.21


    • Cardiovascular | Surgical
      Abbott Wins Expanded Medicare Coverage for MitraClip

      Abbott Wins Expanded Medicare Coverage for MitraClip

      Includes patients with secondary (or functional) mitral regurgitation resulting from heart failure.
      Abbott Laboratories 01.20.21

    • Samsara Vision Appoints Three New Board Members

      Samsara Vision Appoints Three New Board Members

      Company recently changed its name from VisionCare Inc.
      Business Wire 01.20.21

    • Diagnostics
      Thermo Fisher Buys Mesa Biotech for $450M

      Thermo Fisher Buys Mesa Biotech for $450M

      Mesa Biotech developed, commercialized a PCR-based rapid POC testing platform for detecting infectious diseases.
      PR Newswire 01.20.21


    • AtriCure Receives FDA Clearance to Expand its Labeling for Cryo Nerve Block Therapy

      AtriCure Receives FDA Clearance to Expand its Labeling for Cryo Nerve Block Therapy

      The expansion includes adolescent patients who can benefit from cryo nerve block therapy during surgical procedures involving the chest wall.
      Business Wire 01.20.21

    • Former Covidien Executive Joins Vesper Medical Board

      Former Covidien Executive Joins Vesper Medical Board

      New board member has over 25 years in sales, marketing and operational leadership roles building innovative technology portfolios.
      Business Wire 01.20.21

    • Ra Medical Pays $2.5 Million to Settle False Claims Investigation

      Ra Medical Pays $2.5 Million to Settle False Claims Investigation

      The company did not admit any liability or wrongdoing.
      Business Wire 01.20.21


    • CHF Solutions Appoints CEO

      CHF Solutions Appoints CEO

      Nestor Jaramillo Jr succeeds John Erb.
      Globe Newswire 01.19.21

    • Surgical
      Freehand Partners with Imperial Medical Solutions

      Freehand Partners with Imperial Medical Solutions

      Supports the introduction of its surgical robots in India, Sri Lanka, Malaysia and the Caribbean.
      Freehand 01.19.21

    • Intersect ENT Announces CMS Approval of Coding Application for Sinus Implant

      Intersect ENT Announces CMS Approval of Coding Application for Sinus Implant

      Establishes new S code for Propel to facilitate specific coding and payment.
      Business Wire 01.19.21


    Trending
    • Telemedicine, Regulatory Changes To Characterize Medtech Industry In 2021
    • Philips Buys Capsule Technologies In $635M Deal
    • Top 10 Trends In The Medical Device And Equipment Industry
    • Haemonetics To Acquire Cardiva For Up To $510M
    • Meeting Critical Ventilator Product Requirements Amid Pandemic
    Breaking News
    • PhysIQ Elects Former Naval Vice Admiral to its Advisory Board
    • First Heart Failure Patient Treated With Impulse Dynamics' CCM Therapy in Brazil
    • Boston Scientific to Acquire Preventice for Up to $925M
    • Evonik Closes LACTEL Absorbable Polymers Acquisition
    • Eitan Medical Receives FDA Clearance for Sapphire Infusion System
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Pharmaceutical Focus: A Look at Combination Products
    • The Printed World: Additive Manufacturing in Medtech
    • The Lost Year: 2020 Year in Review
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Astaxanthin Microencapsulated with Spirulina Targets ‘Mental Agility’ and Healthy Aging
    Ingredient Manufacturers Discuss the E-Sports Market
    Euromonitor Names Top Ten Trends for 2021
    Coatings World

    Latest Breaking News From Coatings World

    IGL Coatings Launches Graphene Reinforced Dual System Ceramic Coating
    Miller Paint Declares Simple Serenity its 2021 Color of the Year
    TAUBMANS Paint by PPG Releases ‘Chromatic Joy’ Palettes
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    PhysIQ Elects Former Naval Vice Admiral to its Advisory Board
    First Heart Failure Patient Treated With Impulse Dynamics' CCM Therapy in Brazil
    Boston Scientific to Acquire Preventice for Up to $925M
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Global Biosciences Co. Selects ValGenesis VLMS
    Eisai Appoints Chief Clinical Officer of Oncology Biz
    Nexelis Acquires GSK Vax Lab in Marburg
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Firmenich Appoints Chief Consumer & Innovation Officer, Global Perfumery
    Top Beauty Brands in the World—And Most Loved Fragrances
    P&G Reports Q2 Results
    Happi

    Latest Breaking News From Happi

    Flow Launches Collagen Waters
    Associations Congratulate Biden & Harris
    David Stanko Joins JPMS
    Ink World

    Latest Breaking News From Ink World

    Morancé Soudure France Adds Comexi F2 MC 10-color Flexo Press
    THIMM Group Installs 1st Koenig & Bauer CorruFLEX
    Cowan Graphics Adds Fujifilm Inca OnsetX3 HS
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Domino grows installation and service teams
    ABG keeps pace with demand with recruitment drive
    Acucote expands FSC-certified portfolio
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Wemy Donates PPE to Teaching Hospital
    First Quality Launches Incognito by Prevail
    Essity Launches Reusable Underwear Product
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    RIVANNA Launches Second-Generation Accuro With Thoracic Functionality
    DJO Acquires Trilliant Surgical
    FDA Breakthrough Device Designation Granted to Spiderwort's Spinal Cord Technology
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Graphene Flagship Launches Redesigned Website

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login